| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Centre for Infectious Diseases and Microbiology, Level 3 ICPMR Building, University of Sydney, Westmead Hospital, Institute Road, Westmead, NSW 2145, Australia
Correspondence
Jonathan Iredell
joni{at}icpmr.wsahs.nsw.gov.au
Bartonella henselae is a fastidious, Gram-negative bacterial pathogen of cats and humans. Previous workers have shown that serial passage in vitro leads to attenuation of virulence-associated attributes such as expression of pili, invasion of human epithelial cell lines and the stimulation of endothelial cell proliferation. In contrast to the published data, it was found that pilin expression is frequently preserved in organisms which have undergone phase variation in vitro. Transition from a slow-growing, dry agar-pitting (DAP) to a faster-growing, smooth non-agar-pitting (SNP) form appears to occur predictably and may reflect competition between two populations growing at different rates. Better survival of the slower-growing (DAP) form may explain its relatively easy retrieval from piliated SNP populations allowed to age on solid media. Pilin expression is associated with auto-agglutination in liquid suspension or broth cultures, and appears to be necessary but not sufficient for expression of the agar-pitting phenotype and for the formation of biofilms. Outer-membrane protein variation is seen in association with phase variation, but lipopolysaccharide expression is preserved in piliated as well as extensively passaged non-piliated isolates. The EagI/HhaI infrequent restriction site-PCR fingerprint, which has been previously used to discriminate between serotypes Marseille and Houston, is shown to alter with phase variation in vitro, and there is evidence that genetic change accompanies these events. The extent of genetic and phenotypic variability of phase-variant B. henselae has previously been underestimated. It may lead to new insights into the pathogenicity of this organism, and must be considered when interpreting data arising from such studies.
This article has been cited by other articles:
|
|
 |
|
  S. Kunz, K. Oberle, A. Sander, C. Bogdan, and U. Schleicher Lymphadenopathy in a Novel Mouse Model of Bartonella-Induced Cat Scratch Disease Results from Lymphocyte Immigration and Proliferation and Is Regulated by Interferon-{alpha}/{beta} Am. J. Pathol., April 1, 2008; 172(4): 1005 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Berghoff, J. Viezens, L. Guptill, M. Fabbi, and M. Arvand Bartonella henselae exists as a mosaic of different genetic variants in the infected host Microbiology, July 1, 2007; 153(7): 2045 - 2051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Riess, G. Raddatz, D. Linke, A. Schafer, and V. A. J. Kempf Analysis of Bartonella Adhesin A Expression Reveals Differences between Various B. henselae Strains Infect. Immun., January 1, 2007; 75(1): 35 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Koh, K. W. Lam, M. Alhede, S. Y. Queck, M. Labbate, S. Kjelleberg, and S. A. Rice Phenotypic Diversification and Adaptation of Serratia marcescens MG1 Biofilm-Derived Morphotypes J. Bacteriol., January 1, 2007; 189(1): 119 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ma, J. L. Simala-Grant, and D. E. Taylor Fucosylation in prokaryotes and eukaryotes Glycobiology, December 1, 2006; 16(12): 158R - 184R. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Schulte, D. Linke, S. Klumpp, M. Schaller, T. Riess, I. B. Autenrieth, and V. A. J. Kempf Bartonella quintana Variably Expressed Outer Membrane Proteins Mediate Vascular Endothelial Growth Factor Secretion but Not Host Cell Adherence Infect. Immun., September 1, 2006; 74(9): 5003 - 5013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Pendle, A. Ginn, and J. Iredell Antimicrobial susceptibility of Bartonella henselae using Etest methodology J. Antimicrob. Chemother., April 1, 2006; 57(4): 761 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Kirby In Vitro Model of Bartonella henselae-Induced Angiogenesis Infect. Immun., December 1, 2004; 72(12): 7315 - 7317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Dillon and J Iredell DdeI RFLP for 16S rDNA typing in Bartonella henselae J. Med. Microbiol., December 1, 2004; 53(12): 1263 - 1265. [Full Text] [PDF]
|
|
|
|
 |
|
 U. Zahringer, B. Lindner, Y. A. Knirel, W. M. R. van den Akker, R. Hiestand, H. Heine, and C. Dehio Structure and Biological Activity of the Short-chain Lipopolysaccharide from Bartonella henselae ATCC 49882T J. Biol. Chem., May 14, 2004; 279(20): 21046 - 21054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Rodrick, B. Dillon, M. Dexter, I. Nicholson, S. Marcel, D. Dickeson, and J. Iredell Culture-Negative Endocarditis Due to Houston Complex Bartonella henselae Acquired in Noumea, New Caledonia J. Clin. Microbiol., April 1, 2004; 42(4): 1846 - 1848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Iredell, D. Blanckenberg, M. Arvand, S. Grauling, E. J. Feil, and R. J. Birtles Characterization of the Natural Population of Bartonella henselae by Multilocus Sequence Typing J. Clin. Microbiol., November 1, 2003; 41(11): 5071 - 5079. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
